CELLINK lanserar nästa generations bioprinters – BIO MDX
Héctor Martínez - Co-founder and CTO - CELLINK AB LinkedIn
LinkedIn. Hector Héctor Martínez. cellink (7)gusten danielsson (6)create the future of medicine (4)bioconvergence (3)erik gateholm (3)erik gatenholm Biomedicinsk tillverkning är i stort behov av förbättrad teknik, och BIO MDX™-serien tillför just detta” säger Héctor Martínez, CTO CELLINK. Kontakta Hector Martinez, Göteborg. Adress: Arvid Detta är Hectors jobbadress på Cellink AB i Göteborg.
Héctor Martínez, CTO and co-founder of CELLINK, received his doctorate in Cartilage Tissue Engineering Oct 16, 2018 Hector Martinez was born in Mexico. Together with one of his fellow students, he has built up Cellink publ. AB, the only company of its kind in the world, carrying out innovations that enable human cells to be grown, Hector Martinez is the Co-founder & CTO at Cellink . Cellink Co-founder & CTO May 2015 4 jul 2016 Cellink har tagit fram ett bläck som gör det möjligt att skriva ut biologisk Då har vi koll på kvaliteten och det är viktigt, säger Hector Martinez. Get Cellink AB (CLLKF:Grey Market) real-time stock quotes, news, price and financial information from CNBC. Hector Martinez.
All about CELLINK
CELLINK Options AB Styrelseledamot Verklig huvudman Data senast uppdaterad 2021-02-17. Hector Daniel Martinez Avila är verklig huvudman eller företrädare för 1 st bolag. Bolag Genom Andel; CELLINK AB Hector Martinez, Cellink AB utsågs till ”Årets Pionjär 2018” och Adam Aljaraidah, Virkesbörsen utsågs till ”Årets Unga Pionjär 2918” när finalen i H.M. Konung Carl XVI Gustafs pris till företagare med utländsk bakgrund gick av stapeln på Kungliga slottet med Konungen som prisutdelare.
Cellinks vd Erik Gatenholm och teknikchef Hector Martinez
Nyheter (9); Media (0); Event (0). Erik Gatenholm, grundare Cellink. Foto: Björn Larsson Rosvall/Exponera. 20 Maj 2020 10:00 View the latest Cellink AB Series B (CLNK.B) stock price, news, historical charts, Chief Financial Officer; Hector Daniel Martinez Avila Chief Technology Officer. Mar 22, 2021 According to Héctor Martínez, CELLINK CTO, “Leveraging synergies across the group, BIO MDX™ is the registered trademark of Cellink AB. Mar 15, 2021 PRNewswire/ -- CELLINK has announced the launch of the BIO MDX™ BIO MDX Series provides just that," says Héctor Martínez, CELLINK CTO. https:// news.cision.com/cellink-ab/r/cellink-launches-the-bio-mdx-series- Hector Martínez, Chief Technology Officer, CELLINK.
The prestigious award goes to entrepreneurs active in Sweden with a foreign background, and aim to highlight and promote entrepreneurship in Sweden.
Fri tanke podcast
He received a doctorate and a graduate degree from Chalmers University of Technology and an CELLINK is a 3D bioprinting company based in Gothenburg, Sweden, and was one of the first companies in the world to offer 3D printable bioink, which is used to print human organs and tissues.
We have also developed the world's most cost-effective and true benchtop 3D bioprinter, the INKREDIBLE+, for scientist interested in joining the 3D bioprinting field and to start bioprinting living tissues at ease. Hector Martinez CTO. Född 1985. CTO sedan 2016. Utbildning och arbetserfarenhet: Som ingenjör inom biomedicinsk teknik erhöll Héctor sin doktorsexamen i broskvävnadsteknik vid Chalmers Tekniska Högskola och har åtta års erfarenhet av biomaterial, vävnadsteknik och 3D bioprintning.
Impossible foods
såpa ytspänning
folkmängd sverige
bolagsverket verklig huvudman stiftelse
frisör gislaved
sketchup pro code
CELLINK lanserar nästa generations bioprinters – BIO MDX
Jun 27, 2019 B33Y 70/00. Applicants CELLINK AB ENGITIX LTD. Inventors FRENGUELLI, Luca MARTINEZ, Hector GATENHOLM, Erik MAZZA, Giuseppe. Se Héctor Martínez profil på LinkedIn, världens största yrkesnätverk. Héctor har angett 1 CTO at CELLINK.
Skatteaterbaring foretagare 2021
forbranning av kol
3D bioprinting startup CELLINK opens new office - 3ders.org
At that level they are trading at 15.73% premium to the analyst consensus target price of 0.00. Analysts covering Cellink AB currently have a consensus Earnings Per Share (EPS) forecast of 0.76 for the next financial year. Our scientists at CELLINK develop novel, cell-specific bioinks for 3D bioprinting of human tissues, such as cartilage, skin and bone. We have also developed the world's most cost-effective and true benchtop 3D bioprinter, the INKREDIBLE+, for scientist interested in joining the 3D bioprinting field and to start bioprinting living tissues at ease. Hector Martinez CTO. Född 1985.